pharma · Acute Myeloid Leukemia · Advanced Hematologic Malignancy · FHTX
Foghorn Therapeutics
Foghorn Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Watertown, USA HQ
2016 Founded
124 Employees
Public company Type
FHTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Watertown, USA
- Founded
- 2016
- Employees
- 124
- Programs
- 5
- Drugs
- 2
- Patents
- 14
Foghorn Therapeutics projects
1 ClinicalTrials.gov programs sponsored by Foghorn Therapeutics.
Foghorn Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Foghorn Therapeutics have?
1 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.